Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000897101-21-000241
Filing Date
2021-03-26
Accepted
2021-03-26 16:05:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ape210433_sc13g.htm SC 13G 49902
  Complete submission text file 0000897101-21-000241.txt   51765
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79996 | Film No.: 21777331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204
Business Address 20 N. MERIDIAN STREET SUITE 801 INDIANAPOLIS IN 46204 317-684-9196
Apexian Pharmaceuticals, Inc. (Filed by) CIK: 0001560913 (see all company filings)

EIN.: 450594393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G